ISIN
CH0013841017
Ticker
LONN
Sector
Sub-Industry
Country
Switzerland
Year Founded
1897
Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.
16,218
Worldwide
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
15.11.2023 | None | Executive member | Buy | CHF 7,088.00 |
01.11.2023 | None | Executive member | Buy | CHF 95,927.90 |
23.10.2023 | None | Executive member | Buy | CHF 327.30 |
19.10.2023 | None | Executive member | Buy | CHF 19,847.60 |
18.10.2023 | None | Non-Executive member | Buy | CHF 495,880.00 |
18.10.2023 | None | Executive member | Buy | CHF 19,481.00 |
23.05.2023 | None | Executive member | Sell | CHF 533,504.40 |
19.05.2023 | None | Executive member | Sell | CHF 298,737.20 |
27.01.2022 | None | Executive member | Buy | CHF 59,163.24 |
CH0013841017
549300EFW4H2TCZ71055
SMI
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.